Stock listing
Frankfurt:HM6A Hypera S.A. Aktie
German listing (Frankfurt) of Hypera S.A. · home listing B3:HYPE3
Follow Hypera S.A. into a list and get an email when it puts out news.
Share price · FWB:HM6A
€3.26 EUR -0.06 (-1.8%)
Close on Nov 20, 2026
- Day range
- €3.26 – €3.26 EURNov 20, 2026
- Market cap
- €2.30B EURAt the close on Nov 20, 2026 · price × 704.0M shares outstanding
- 52-week range
- €3.22 – €4.91 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €1,317 EURMedian day 0 shares · 49 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| B3:HYPE3 · Home | 21.77 BRL | -0.56 (-2.5%) | 3,368,300 | 21.98 | 22.19 | 21.52 | 22.33 | Close on Nov 19, 2026 |
| OTC:HYPMY | $3.74 USD | +0.045 (+1.2%) | 200 | $3.74 | $3.74 | $3.74 | $3.695 | Close on Nov 20, 2026 |
| Frankfurt:HM6A | €3.26 EUR | -0.06 (-1.8%) | — | €3.26 | €3.26 | €3.26 | €3.32 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:HM6A · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €3.394 | +0.011 | +0.3% | €3.394 | €3.394 | €3.394 | 0 | |
| €3.383 | +0.082 | +2.5% | €3.383 | €3.383 | €3.383 | 0 | |
| €3.301 | -0.17 | -4.9% | €3.301 | €3.301 | €3.301 | 0 | |
| €3.471 | +0.08 | +2.4% | €3.471 | €3.471 | €3.471 | 0 | |
| €3.391 | -0.174 | -4.9% | €3.391 | €3.391 | €3.391 | 4,076 | |
| €3.565 | +0.03 | +0.8% | €3.46 | €3.598 | €3.443 | 4,076 | |
| €3.535 | -0.003 | -0.1% | €3.535 | €3.535 | €3.535 | 0 | |
| €3.538 | +0.082 | +2.4% | €3.538 | €3.538 | €3.538 | 0 | |
| €3.456 | -0.248 | -6.7% | €3.456 | €3.456 | €3.456 | 3,800 | |
| €3.704 | -0.892 | -19.4% | €4.491 | €4.493 | €3.217 | 3,800 | |
| €4.596 | +0.029 | +0.6% | €4.596 | €4.596 | €4.596 | 0 | |
| €4.567 | -0.109 | -2.3% | €4.567 | €4.567 | €4.567 | 0 | |
| €4.676 | +0.223 | +5.0% | €4.676 | €4.676 | €4.676 | 0 | |
| €4.453 | -0.16 | -3.5% | €4.453 | €4.453 | €4.453 | 0 | |
| €4.613 | +0.217 | +4.9% | €4.613 | €4.613 | €4.613 | 0 | |
| €4.396 | -0.035 | -0.8% | €4.396 | €4.396 | €4.396 | 0 | |
| €4.431 | -0.249 | -5.3% | €4.431 | €4.431 | €4.431 | 0 | |
| €4.68 | +0.027 | +0.6% | €4.548 | €4.69 | €4.538 | 1,730 | |
| €4.653 | +0.021 | +0.5% | €4.653 | €4.653 | €4.653 | 0 | |
| €4.632 | -0.063 | -1.3% | €4.632 | €4.632 | €4.632 | 0 | |
| €4.695 | +0.012 | +0.3% | €4.695 | €4.695 | €4.695 | 0 | |
| €4.683 | -0.179 | -3.7% | €4.683 | €4.683 | €4.683 | 0 | |
| €4.862 | +0.172 | +3.7% | €4.659 | €4.912 | €4.658 | 600 | |
| €4.69 | +0.49 | +11.7% | €4.69 | €4.69 | €4.69 | 0 | |
| €4.20 | +0.072 | +1.7% | €4.20 | €4.20 | €4.20 | 0 | |
| €4.128 | +0.223 | +5.7% | €4.128 | €4.128 | €4.128 | 0 | |
| €3.905 | -0.069 | -1.7% | €3.905 | €3.905 | €3.905 | 0 | |
| €3.974 | +0.185 | +4.9% | €3.974 | €3.974 | €3.974 | 0 | |
| €3.789 | -0.218 | -5.4% | €3.789 | €3.789 | €3.789 | 0 | |
| €4.007 | +0.03 | +0.8% | €4.007 | €4.007 | €4.007 | 0 | |
| €3.977 | -0.068 | -1.7% | €3.977 | €3.977 | €3.977 | 0 | |
| €4.045 | -0.057 | -1.4% | €4.045 | €4.045 | €4.045 | 0 | |
| €4.102 | +0.167 | +4.2% | €4.102 | €4.102 | €4.102 | 0 | |
| €3.935 | +0.08 | +2.1% | €3.935 | €3.935 | €3.935 | 0 | |
| €3.855 | +0.026 | +0.7% | €3.855 | €3.855 | €3.855 | 0 | |
| €3.829 | -0.04 | -1.0% | €3.829 | €3.829 | €3.829 | 0 | |
| €3.869 | +0.026 | +0.7% | €3.869 | €3.869 | €3.869 | 0 | |
| €3.843 | -0.014 | -0.4% | €3.843 | €3.843 | €3.843 | 0 | |
| €3.857 | +0.134 | +3.6% | €3.857 | €3.857 | €3.857 | 0 | |
| €3.723 | -0.03 | -0.8% | €3.723 | €3.723 | €3.723 | 0 | |
| €3.753 | +0.031 | +0.8% | €3.753 | €3.753 | €3.753 | 0 | |
| €3.722 | -0.028 | -0.7% | €3.722 | €3.722 | €3.722 | 0 | |
| €3.75 | -0.023 | -0.6% | €3.75 | €3.75 | €3.75 | 0 | |
| €3.773 | +0.027 | +0.7% | €3.773 | €3.773 | €3.773 | 0 | |
| €3.746 | +0.02 | +0.5% | €3.746 | €3.746 | €3.746 | 0 | |
| €3.726 | +0.039 | +1.1% | €3.726 | €3.726 | €3.726 | 0 | |
| €3.687 | +0.046 | +1.3% | €3.687 | €3.687 | €3.687 | 0 | |
| €3.641 | +0.09 | +2.5% | €3.641 | €3.641 | €3.641 | 0 | |
| €3.551 | +0.10 | +2.9% | €3.554 | €3.554 | €3.546 | 196 | |
| €3.451 | +0.035 | +1.0% | €3.451 | €3.451 | €3.451 | 0 | |
| €3.416 | -0.489 | -12.5% | €3.416 | €3.416 | €3.416 | 0 | |
| €3.905 | +0.411 | +11.8% | €3.598 | €3.912 | €3.588 | 1,990 | |
| €3.494 | +0.012 | +0.3% | €3.494 | €3.494 | €3.494 | 0 | |
| €3.482 | +0.088 | +2.6% | €3.482 | €3.482 | €3.482 | 0 | |
| €3.394 | +0.018 | +0.5% | €3.394 | €3.394 | €3.394 | 0 | |
| €3.376 | -0.037 | -1.1% | €3.376 | €3.376 | €3.376 | 0 | |
| €3.413 | +0.051 | +1.5% | €3.413 | €3.413 | €3.413 | 0 |
- Ticker
- Frankfurt:HM6A
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Apr 28, 2026
Press Release 1T26 (PORT e ENG)
Latest earnings call · Aug 7, 2026
Hypera (B3:HYPE3) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 7, 2026
Q2 2026 Earnings Presentation
Earnings · 7 slides
Latest news
Press Release 1T26 (PORT e ENG)
Apr 28, 2026
Closed €3.74 (-2.8%) on Apr 29, 2026
Notice to Shareholders - Capital Increase
Feb 3, 2026
Closed €4.10 (-1.3%) on Feb 4, 2026
Material Fact – Capital Increase
Feb 3, 2026
Closed €4.10 (-1.3%) on Feb 4, 2026
Hypera S.A. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 3 in the last 12 months · 6 in all · newest Apr 28, 2026 · oldest 2025
- Calls
- 17 calls with a replay · 17 with a transcript · latest Aug 7, 2026
- Decks
- 17 decks · latest Aug 7, 2026
Where Hypera S.A. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| B3:HYPE3 · Home listing | B3 | Brazil | BRL |
| B3:HYPE3F | B3 | Brazil | BRL |
| OTC:HYPMY | OTC | United States | USD |
| LS Exchange:A2JETE | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2JETE | Lang & Schwarz | Germany | EUR |
| Frankfurt:HM6A · This page | Frankfurt | Germany | EUR |
| Stuttgart:HM6A | Stuttgart | Germany | EUR |
Valuation
P/E 8.5× against a median of 21.9×: the lowest of 11 Pharmaceuticals companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 19, 2026
- Enterprise value
- 21.11B BRL
- P/E
- 8.5×
- EV/sales
- 2.3×
- EV/EBITDA
- 7.4×
- Price/book
- 1.0×
- Gross margin
- 58.9%
- Operating margin
- 28.0%
- Net margin
- 20.1%
- Debt to equity
- 0.5×
- Beta
- No index for this market yet
Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Hypera S.A. · BMFBOVESPA:HYPE3 | US$2.59B | US$3.57B | 8.5× | 2.3× | 7.4× | 1.0× | 20.1% | 0.5× | n/a |
| China Medical System Holdings Ltd. · HKEX:867 | US$2.87B | US$2.13B | 12.8× | 1.7× | 7.7× | 1.1× | 18.1% | 0.1× | n/a |
| Joincare Pharmaceutical Group Industry Co., Ltd. Class A · SSE:600380 | US$2.80B | US$1.16B | 16.5× | 0.6× | n/a | 1.3× | 8.4% | 0.1× | n/a |
| Livzon Pharmaceutical Group, Inc. Class A · SZSE:000513 | US$2.72B | US$1.65B | 11.7× | 1.1× | n/a | 1.4× | 15.2% | 0.0× | n/a |
| Bavarian Nordic A/S · OMXCOP:BAVA | US$2.70B | US$2.38B | 20.5× | 2.6× | 8.6× | 1.4× | 14.2% | 0.0× | n/a |
| Betta Pharmaceuticals Co., Ltd. Class A · SZSE:300558 | US$2.64B | US$2.72B | 66.1× | 4.8× | n/a | 2.7× | 7.0% | 0.2× | n/a |
| Hanmi Science Co., Ltd · KRX:008930 | US$2.60B | US$2.53B | 23.2× | 2.5× | 57.2× | 3.3× | 10.8% | 0.0× | n/a |
| Hybio Pharmaceutical Co., Ltd. Class A · SZSE:300199 | US$2.60B | US$2.71B | 43.1× | 11.8× | n/a | 16.1× | 26.3% | 0.9× | n/a |
| Kangmei Pharmaceutical Co., Ltd Class A · SSE:600518 | US$2.57B | US$2.37B | 189× | 3.3× | n/a | 2.3× | 1.9% | 0.0× | n/a |
| Granules India Limited · NSE:GRANULES | US$2.42B | US$2.32B | 31.4× | 3.6× | 16.1× | 3.4× | 12.1% | 0.2× | n/a |
| Prestige Consumer Healthcare Inc. · NYSE:PBH | US$2.35B | US$4.39B | 15.2× | 3.8× | 13.4× | 1.2× | 13.3% | 1.1× | 0.34 |
| Median of the others | US$2.62B | US$2.37B | 21.9× | 2.9× | 13.4× | 1.9× | 12.7% | 0.1× | 0.34 |
Forecasts
Analysts' consensus from EODHD, read Nov 15, 2026. Not 6ix's view and not investment advice.
- Price target
- 29.92 BRL · Analysts' mean
- EPS, year to Dec 2026
- 2.67 · 7 analysts
- Revenue, year to Dec 2026
- 9.25B · 11 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Breno Toledo Pires de Oliveira | Chief Executive Officer (CEO) |
| Ramon Sanches Frutuoso Silva | Chief Financial Officer (CFO) and IRO |
| Pharmacy Purchase Price | IR contacts |
| Adalmario Ghovatto Satheler do Couto | Officer |
| Juliana Aguinaga Damião Salem | Officer |
| Rafael Vito Batista | Officer |
Board
| Director | Role |
|---|---|
| Álvaro Stainfeld Link | Chairman of the Board of Directors |
| Bernardo Malpica Hernández | Member of the Board of Directors |
| Cláudio Ermirio de Moraes | Member of the Board of Directors |
| Eliana Helena de Gregório Ambrosio Chimenti | Independent Member of the Board of Directors |
| Esteban Malpica Fomperosa | Member of the Board of Directors |
| João Alves de Queiroz Filho | Member of the Board of Directors |
| João Henrique Batista de Souza Schmidt | Member of the Board of Directors |
| Luciana Cavalheiro Fleischner Alves de Queiroz | Member of the Board of Directors |
| Mauro Gentile Rodrigues da Cunha | Independent Member of the Board of Directors |
| Rachel de Oliveira Maia | Independent Member of the Board of Directors |
Events
- Next results
- Mar 11, 2027 (expected)
Calls
| Call | When | Status |
|---|---|---|
| Hypera (B3:HYPE3) Q2 2026 Earnings Call | Fri, Aug 07, 2026 · 10:00 AM ET | Replay |
| Hypera (B3:HYPE3) Q4 2025 Earnings Call | Fri, Mar 13, 2026 · 11:00 AM ET | Replay |
| Hypera (B3:HYPE3) Q3 2025 Earnings Call | Wed, Oct 29, 2025 · 10:00 AM ET | Replay |
| Hypera (B3:HYPE3) Q2 2025 Earnings Call | Thu, Aug 07, 2025 · 10:00 AM ET | Replay |
| Hypera (B3:HYPE3) Q1 2025 Earnings Call | Thu, Apr 24, 2025 · 10:00 AM ET | Replay |
| Hypera (B3:HYPE3) Q4 2024 Earnings Call | Fri, Mar 21, 2025 · 10:00 AM ET | Replay |
| Hypera (B3:HYPE3) Q3 2024 Earnings Call | Thu, Nov 14, 2024 · 10:00 AM ET | Replay |
| Hypera (B3:HYPE3) Q2 2024 Earnings Call | Fri, Jul 26, 2024 · 10:00 AM ET | Replay |
| Hypera (B3:HYPE3) Q1 2024 Earnings Call | Mon, Apr 29, 2024 · 10:00 AM ET | Replay |
| Hypera (B3:HYPE3) Q4 2023 Earnings Call | Thu, Mar 14, 2024 · 10:00 AM ET | Replay |
All 17 calls
| Call | When | Status |
|---|---|---|
| Hypera (B3:HYPE3) Q3 2023 Earnings Call | Fri, Oct 27, 2023 · 10:00 AM ET | Replay |
| Hypera (B3:HYPE3) Q2 2023 Earnings Call | Fri, Jul 28, 2023 · 10:00 AM ET | Replay |
| Hypera (B3:HYPE3) Q1 2023 Earnings Call | Fri, Apr 28, 2023 · 10:00 AM ET | Replay |
| Hypera (B3:HYPE3) Q4 2022 Earnings Call | Fri, Feb 17, 2023 · 10:00 AM ET | Replay |
| Hypera (B3:HYPE3) Q3 2022 Earnings Call | Fri, Oct 28, 2022 · 10:00 AM ET | Replay |
| Hypera (B3:HYPE3) Q2 2022 Earnings Call | Fri, Jul 29, 2022 · 10:00 AM ET | Replay |
| Hypera (B3:HYPE3) Q1 2022 Earnings Call | Fri, Apr 29, 2022 · 10:00 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Oct 27, 2026 · After close | +1.4% |
| Q2 2026 | Aug 6, 2026 · After close | +1.3% |
| Q1 2026 | Apr 21, 2026 · After close | −2.1% |
| Q4 2025 | Mar 11, 2026 · After close | −2.3% |
| Q3 2025 | Oct 27, 2025 · After close | −0.5% |
| Q2 2025 | Aug 5, 2025 · After close | +0.4% |
| Q1 2025 | Apr 23, 2025 · After close | +12.3% |
| Q3 2024 | Nov 13, 2024 · After close | −0.3% |
| Q2 2024 | Jul 25, 2024 · After close | +5.8% |
| Q1 2024 | Apr 25, 2024 · After close | +5.2% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2023 | Mar 13, 2024 · After close | −3.7% |
| Q3 2023 | Oct 26, 2023 · After close | −8.3% |
| Q2 2023 | Jul 27, 2023 · After close | −0.2% |
| Q1 2023 | Apr 27, 2023 · After close | +3.5% |
| Q4 2022 | Feb 22, 2023 · After close | +0.7% |
| Q3 2022 | Oct 27, 2022 · After close | +1.7% |
| Q2 2022 | Jul 28, 2022 · After close | +5.2% |
| Q1 2022 | Apr 28, 2022 · After close | −1.9% |
| Q4 2021 | Feb 24, 2022 · After close | +2.8% |
| Quarter to Sep 30, 2021 | Oct 21, 2021 · After close | −2.1% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 2026 Earnings Presentation | Earnings | 7 slides | Aug 7, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 8 slides | Mar 13, 2026 |
| Q3 2025 Earnings Presentation | Earnings | 7 slides | Oct 29, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 7 slides | Aug 7, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 6 slides | Apr 24, 2025 |
| Q4 2024 Earnings Presentation | Earnings | 8 slides | Mar 21, 2025 |
| Q3 2024 Earnings Presentation | Earnings | 7 slides | Nov 14, 2024 |
| Q2 2024 Earnings Presentation | Earnings | 7 slides | Jul 26, 2024 |
| Q1 2024 Earnings Presentation | Earnings | 7 slides | Apr 29, 2024 |
| Q4 2023 Earnings Presentation | Earnings | 10 slides | Mar 14, 2024 |
All 17 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2023 Earnings Presentation | Earnings | 9 slides | Oct 27, 2023 |
| Q2 2023 Earnings Presentation | Earnings | 9 slides | Jul 28, 2023 |
| Q1 2023 Earnings Presentation | Earnings | 7 slides | Apr 28, 2023 |
| Q4 2022 Earnings Presentation | Earnings | 10 slides | Feb 17, 2023 |
| Q3 2022 Earnings Presentation | Earnings | 8 slides | Oct 28, 2022 |
| Q2 2022 Earnings Presentation | Earnings | 9 slides | Jul 29, 2022 |
| Q1 2022 Earnings Presentation | Earnings | 8 slides | Apr 29, 2022 |
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Rights offering of common shares Announced: BRL 1.15B–BRL 1.5B · BRL 21.25 a share Buyers: Votorantim S.A. (shares in an amount of up to R$1,000,000,000.00, subject to availability of unsubscribed shares) Insiders: The controlling shareholder group has undertaken to fully exercise its preemptive rights and take up unsubscribed shares to ensure the Minimum Amount; Votorantim S.A. undertook to subscribe up to R$1,000,000,000.00. Use of proceeds: Strengthen capital structure by reducing net debt, improving operational efficiency and expanding capacity for organic and inorganic growth. | Feb 3, 2026 | US$219.86M |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in BRL
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.70B | 7.44B | 7.91B | 7.55B | 5.94B | 4.09B | 3.29B | 3.72B | 3.50B | 3.23B |
| Cost of revenue | 3.35B | 3.06B | 2.92B | 2.78B | 2.13B | 1.46B | 1.21B | 1.06B | 926.7M | 833.3M |
| Gross profit | 4.35B | 4.38B | 5.00B | 4.76B | 3.80B | 2.63B | 2.09B | 2.67B | 2.57B | 2.39B |
| Research and development | 134.7M | 145.5M | 169.5M | 159.4M | 126.7M | 151.7M | 128.7M | 73.9M | 98.8M | 73.3M |
| Selling, general and administrative | 73.2M | 89.3M | 84.4M | 92.8M | 67.4M | 48.2M | 42.8M | 49.8M | 172.4M | 145.7M |
| Operating income | 1.74B | 1.80B | 2.50B | 2.46B | 2.04B | 1.29B | 1.09B | 1.23B | 1.16B | 1.03B |
| Depreciation and amortization | 317.2M | 281.1M | 238.3M | 169.1M | 133.7M | 121.5M | 120.4M | 88.9M | 76.9M | 72.2M |
| EBITDA | 2.05B | 2.08B | 2.74B | 2.63B | 2.17B | 1.41B | 1.21B | 1.32B | 1.24B | 1.10B |
| Interest expense | 1.08B | 1.04B | 1.35B | 1.04B | 383.2M | 201.3M | 43.2M | 46.2M | 67.5M | 228.3M |
| Income before tax | 900.1M | 979.2M | 1.51B | 1.61B | 1.64B | 1.24B | 1.10B | 1.23B | 1.21B | 835.5M |
| Income tax | -290.8M | -353.8M | -141.6M | -95.3M | 26.6M | -78.2M | -88.9M | 94.5M | 101.9M | 188.3M |
| Net income | 1.20B | 1.34B | 1.65B | 1.70B | 1.33B | 1.30B | 1.16B | 1.13B | 964.9M | 1.18B |
| Earnings per share, basic | 1.86 | 2.10 | 2.58 | 2.65 | 2.08 | 2.03 | 1.82 | 1.77 | 1.52 | 1.84 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.65B | 1.74B | 2.58B | 2.86B | 2.29B | 4.74B | 2.25B | 1.65B | 1.52B | 1.35B |
| Short-term investments | -168.0M | -518.3M | -834.8M | -812.4M | -212.8M | -303.9M | -275.2M | |||
| Receivables | 2.08B | 2.25B | 2.65B | 3.08B | 2.67B | 1.57B | 1.62B | 1.46B | 1.22B | 1.02B |
| Inventory | 2.08B | 1.94B | 2.19B | 2.20B | 1.30B | 920.8M | 664.6M | 596.7M | 454.8M | 431.3M |
| Current assets | 6.05B | 6.68B | 8.08B | 8.53B | 6.49B | 7.90B | 4.74B | 4.26B | 3.93B | 5.21B |
| Property, plant and equipment | 4.23B | 3.90B | 3.56B | 2.82B | 2.10B | 1.55B | 1.17B | 963.9M | 906.8M | 943.7M |
| Goodwill | 7.34B | 7.34B | 7.34B | 7.37B | 7.37B | 4.31B | 4.27B | 4.27B | 4.27B | 4.27B |
| Total assets | 28.6B | 24.6B | 24.5B | 23.8B | 19.8B | 17.2B | 11.9B | 10.6B | 10.1B | 11.4B |
| Accounts payable | 575.7M | 984.1M | 389.7M | 1.31B | 790.8M | 275.5M | 457.8M | 198.1M | 178.3M | 124.9M |
| Current liabilities | 4.11B | 3.94B | 4.64B | 5.23B | 2.78B | 2.62B | 1.59B | 1.41B | 1.71B | 1.74B |
| Long-term debt | 8.01B | 7.99B | 7.82B | 7.38B | 6.80B | 5.05B | 1.29B | 457.8M | 318.5M | 684.0M |
| Total debt | 9.49B | 9.40B | 10.1B | 9.76B | 7.46B | 5.59B | 1.43B | 582.4M | 676.0M | 910.9M |
| Total liabilities | 16.1B | 12.5B | 13.0B | 13.1B | 9.98B | 8.01B | 3.21B | 2.29B | 2.39B | 2.68B |
| Shareholders' equity | 12.5B | 12.1B | 11.5B | 10.6B | 9.83B | 9.24B | 8.71B | 8.27B | 7.74B | 8.71B |
| Shares outstanding | 643.1M | 637.9M | 637.8M | 639.1M | 639.5M | 638.3M | 639.9M | 639.5M | 636.4M | 641.5M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 1.43B | 2.54B | 2.40B | 2.04B | 1.40B | 1.18B | 823.9M | 1.07B | 932.6M | 881.8M |
| Capital spending | -532.3M | -772.3M | -812.7M | -1.51B | -838.9M | -1.93B | -361.6M | -220.9M | -211.9M | -214.1M |
| Free cash flow | 896.1M | 1.77B | 1.58B | 529.3M | 560.2M | -744.2M | 462.3M | 845.6M | 720.7M | 667.7M |
| Cash from investing | -690.8M | -592.4M | -791.2M | -1.74B | -4.41B | -1.90B | -306.5M | -170.5M | 659.0M | 2.45B |
| Cash from financing | -831.3M | -2.79B | -1.89B | 279.0M | 557.1M | 3.21B | 82.2M | -771.2M | -1.42B | -4.74B |
| Dividends paid | -627.8M | -787.3M | -759.9M | -806.2M | -745.9M | -682.5M | -623.4M | -633.0M | -409.8M | -316.1M |
| Share buybacks | -23.1M | -55.8M | -88.5M | -87.0M | -128.7M | 12.1M | -72.2M | -4.28M | -1.12B | -104.8M |
| Change in cash | -93.8M | -841.6M | -281.6M | 575.4M | -2.46B | 2.50B | 599.6M | 124.7M | 174.1M | -1.41B |
Cap table
Built by 6ix from Hypera S.A.’s releases · as of Feb 3, 2026
- Common shares
- 703,995,955
- Fully diluted
- 703,995,955
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 703,995,955 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 703,995,955 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Adalmario Ghovatto Satheler do Couto | Officer · Since at least Nov 5, 2026 |
| Álvaro Stainfeld Link | Chairman of the Board of Directors · Since at least Aug 6, 2025 |
| Bernardo Malpica Hernández | Member of the Board of Directors · Since at least Nov 5, 2026 |
| Breno Toledo Pires de Oliveira | Chief Executive Officer (CEO) · Since at least Nov 5, 2026 |
| Cláudio Ermirio de Moraes | Member of the Board of Directors · Since at least Aug 6, 2025 |
| Eliana Helena de Gregório Ambrosio Chimenti | Independent Member of the Board of Directors · Since at least Oct 28, 2025 |
| Esteban Malpica Fomperosa | Member of the Board of Directors · Since at least Nov 5, 2026 |
| João Alves de Queiroz Filho | Member of the Board of Directors · Since at least Aug 6, 2025 |
| João Henrique Batista de Souza Schmidt | Member of the Board of Directors · Since at least Oct 28, 2025 |
| Juliana Aguinaga Damião Salem | Officer · Since at least Nov 5, 2026 |
All 16 people
| Person | Seat |
|---|---|
| Luciana Cavalheiro Fleischner Alves de Queiroz | Member of the Board of Directors · Since at least Oct 28, 2025 |
| Mauro Gentile Rodrigues da Cunha | Independent Member of the Board of Directors · Since at least Oct 28, 2025 |
| Pharmacy Purchase Price | IR contacts · Since at least Apr 28, 2026 |
| Rachel de Oliveira Maia | Independent Member of the Board of Directors · Since at least Oct 28, 2025 |
| Rafael Vito Batista | Officer · Since at least Nov 5, 2026 |
| Ramon Sanches Frutuoso Silva | Chief Financial Officer (CFO) and IRO · Since at least Feb 3, 2026 |
Log in to ask 6ix AI your own questions about Hypera S.A.